These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. The pathophysiology of atherosclerosis. Mitchell ME; Sidawy AN Semin Vasc Surg; 1998 Sep; 11(3):134-41. PubMed ID: 9763113 [TBL] [Abstract][Full Text] [Related]
28. Arteriosclerosis. Impairment of cellular interactions in the arterial wall. Van Hinsbergh VW Ann N Y Acad Sci; 1992 Dec; 673():321-30. PubMed ID: 1485729 [TBL] [Abstract][Full Text] [Related]
29. Fibrous and lipid-rich atherosclerotic plaques are part of interchangeable morphologies related to inflammation: a concept. van der Wal AC; Becker AE; van der Loos CM; Tigges AJ; Das PK Coron Artery Dis; 1994 Jun; 5(6):463-9. PubMed ID: 7952404 [TBL] [Abstract][Full Text] [Related]
30. Atherosclerosis and the vascular biology of aging. Bilato C; Crow MT Aging (Milano); 1996 Aug; 8(4):221-34. PubMed ID: 8904951 [TBL] [Abstract][Full Text] [Related]
31. The cellular pathobiology of atherosclerosis in 1983. Wissler RW Adv Exp Med Biol; 1985; 183():1-16. PubMed ID: 3898743 [TBL] [Abstract][Full Text] [Related]
32. Progression of atherosclerosis: the cell biology. Chait A Eur Heart J; 1987 Aug; 8 Suppl E():15-22. PubMed ID: 3315672 [TBL] [Abstract][Full Text] [Related]
33. Immunology of atherosclerosis. Demonstration of heat shock protein 60 expression and T lymphocytes bearing alpha/beta or gamma/delta receptor in human atherosclerotic lesions. Kleindienst R; Xu Q; Willeit J; Waldenberger FR; Weimann S; Wick G Am J Pathol; 1993 Jun; 142(6):1927-37. PubMed ID: 8099471 [TBL] [Abstract][Full Text] [Related]
34. Benefits of gliclazide in the atherosclerotic process: decrease in monocyte adhesion to endothelial cells. Renier G; Mamputu JC; Serri O Metabolism; 2003 Aug; 52(8 Suppl 1):13-8. PubMed ID: 12939734 [TBL] [Abstract][Full Text] [Related]
35. Lipid lowering promotes accumulation of mature smooth muscle cells expressing smooth muscle myosin heavy chain isoforms in rabbit atheroma. Aikawa M; Rabkin E; Voglic SJ; Shing H; Nagai R; Schoen FJ; Libby P Circ Res; 1998 Nov; 83(10):1015-26. PubMed ID: 9815149 [TBL] [Abstract][Full Text] [Related]
36. Monocyte/macrophage recruitment and expression of endothelial adhesion proteins in human atherosclerotic lesions. Duplàa C; Couffinhal T; Labat L; Moreau C; Petit-Jean ME; Doutre MS; Lamazière JM; Bonnet J Atherosclerosis; 1996 Apr; 121(2):253-66. PubMed ID: 9125299 [TBL] [Abstract][Full Text] [Related]
37. Antifibrinolytic properties of the vascular wall. Dependence on the history of smooth muscle cell doublings in vitro and in vivo. Christ G; Hufnagl P; Kaun C; Mundigler G; Laufer G; Huber K; Wojta J; Binder BR Arterioscler Thromb Vasc Biol; 1997 Apr; 17(4):723-30. PubMed ID: 9108786 [TBL] [Abstract][Full Text] [Related]
38. Haemostatic factors and atherogenesis. Smith EB Atherosclerosis; 1996 Aug; 124(2):137-43. PubMed ID: 8830927 [TBL] [Abstract][Full Text] [Related]
39. Model system to study interaction of platelets with damaged arterial wall. II. Inhibition of smooth muscle cell proliferation by dipyridamole and AH-P719. Ingerman-Wojenski CM; Silver MJ Exp Mol Pathol; 1988 Feb; 48(1):116-34. PubMed ID: 2826219 [TBL] [Abstract][Full Text] [Related]